BRWA
PCRX icon

B. Riley Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History

B. Riley Wealth Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,577
Closed -$253K – 868
2019
Q4 		$253K Buy
+5,577
New +$237K 0.02% 673
2019
Q3 		– Sell
-5,053
Closed -$220K – 841
2019
Q2 		$220K Buy
+5,053
New +$215K 0.02% 680
2019
Q1 		– Sell
-5,550
Closed -$239K – 766
2018
Q4 		$239K Sell
5,550
-880
-14% -$41.1K 0.03% 517
2018
Q3 		$317K Sell
6,430
-117
-2% -$5.06K 0.04% 478
2018
Q2 		$210K Buy
+6,547
New +$226K 0.03% 597
2014
Q3 		– Sell
-1,485
Closed -$136K – 1521
2014
Q2 		$136K Buy
+1,485
New +$113K 0.03% 599

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return